2006
DOI: 10.1111/j.1610-0387.2006.06085.x
|View full text |Cite
|
Sign up to set email alerts
|

Safety and efficiency of perilesional sclerotherapy in leg ulcer patients with postthrombotic syndrome and/or oral anticoagulation with phenprocoumon

Abstract: Perilesional sclerotherapy with foam is a safe and efficient therapy for patients with chronic venous leg ulcers even with postthrombotic syndrome and/ or ongoing anticoagulation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
22
0
3

Year Published

2010
2010
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 40 publications
(25 citation statements)
references
References 15 publications
0
22
0
3
Order By: Relevance
“…[38][39][40][41][42][43][44] Sclerotherapy of varices in the region of venous ulcers improves the healing rate. [45][46][47][48] (GRADE 1B). Recently catheter-directed foam sclerotherapy for chronic venous leg ulcers showed a good healing rate in a prospective case-control study.…”
Section: Assessment Of the Outcome After Sclerotherapymentioning
confidence: 99%
“…[38][39][40][41][42][43][44] Sclerotherapy of varices in the region of venous ulcers improves the healing rate. [45][46][47][48] (GRADE 1B). Recently catheter-directed foam sclerotherapy for chronic venous leg ulcers showed a good healing rate in a prospective case-control study.…”
Section: Assessment Of the Outcome After Sclerotherapymentioning
confidence: 99%
“…Here, either surgical ("vein stripping") or endoluminal techniques may be employed. Foam sclerotherapy of (periulcerous) insufficient veins is worthwhile, particularly when contraindications to surgery exist [6].…”
Section: Venous Leg Ulcermentioning
confidence: 99%
“…"Nährvenen" durch eine Sklerosierungstherapie ermöglicht eine si gnifikante Verkürzung der Heilungsdau er [16]. Die periulzeröse Sklerosierungs therapie ist dabei auch bei Patienten mit postthrombotischem Syndrom und unter laufender oraler Antikoagulation möglich [20]. Die Sklerosierungstherapie kann da bei sowohl mit flüssigen als auch mit auf geschäumten Sklerosierungsmitteln erfol gen. Das einzige in Deutschland zugelas sene Sklerosierungsmittel mit dem Wirk stoff Polidocanol ist seit Ende 2009 in bei den Varianten als Medikation zugelassen.…”
Section: Kausale Therapie Nicht Vernachlässigenunclassified